Header Logo

Connection

TARIQ SHAFI to Humans

Back to Details
This is a "connection" page, showing publications TARIQ SHAFI has written about Humans.
TARIQ SHAFI
Connection Strength
1.077
Humans
  1. Mechanisms, Magnitude, and Consequence of Acute Estimated Glomerular Filtration Rate Change With Guideline-Directed Medical Therapy Initiation in Heart Failure. Am J Cardiol. 2026 Aug 01; 272:32-39.
    View in: PubMed
    Score: 0.026
  2. Adequacy Measurement for the 21st Century: Revisiting Kt/Vurea. Adv Kidney Dis Health. 2025 09; 32(5):411-421.
    View in: PubMed
    Score: 0.025
  3. Is There a Role for SGLT2 Inhibitors in Patients with End-Stage Kidney Disease? Curr Hypertens Rep. 2024 Dec; 26(12):463-474.
    View in: PubMed
    Score: 0.023
  4. Individualized Risk of CKD Progression among US Adults. J Am Soc Nephrol. 2024 Aug 01; 35(8):1076-1083.
    View in: PubMed
    Score: 0.023
  5. Refining GFR estimation: a quest for the unobservable truth? Kidney Int. 2024 03; 105(3):435-437.
    View in: PubMed
    Score: 0.022
  6. Incidence and Risk Factors for Pruritus in Patients with Nondialysis CKD. Clin J Am Soc Nephrol. 2023 02 01; 18(2):193-203.
    View in: PubMed
    Score: 0.020
  7. Quantifying Individual-Level Inaccuracy in Glomerular Filtration Rate Estimation : A Cross-Sectional Study. Ann Intern Med. 2022 08; 175(8):1073-1082.
    View in: PubMed
    Score: 0.020
  8. Assessment of glycemia in chronic kidney disease. BMC Med. 2022 04 13; 20(1):117.
    View in: PubMed
    Score: 0.019
  9. Trajectories of Uremic Symptom Severity and Kidney Function in Patients with Chronic Kidney Disease. Clin J Am Soc Nephrol. 2022 04; 17(4):496-506.
    View in: PubMed
    Score: 0.019
  10. A metabolomics approach identified toxins associated with uremic symptoms in advanced chronic kidney disease. Kidney Int. 2022 02; 101(2):369-378.
    View in: PubMed
    Score: 0.019
  11. Patients' and family members' perspectives on arrhythmias and sudden death in dialysis: the HeartLink focus groups pilot study. BMC Nephrol. 2021 05 27; 22(1):199.
    View in: PubMed
    Score: 0.018
  12. Drug Selection for Treating Hypertension in Dialysis Patients: More to Consider than BP-Lowering Potency. Clin J Am Soc Nephrol. 2020 08 07; 15(8):1084-1086.
    View in: PubMed
    Score: 0.017
  13. Contribution of 'clinically negligible' residual kidney function to clearance of uremic solutes. Nephrol Dial Transplant. 2020 05 01; 35(5):846-853.
    View in: PubMed
    Score: 0.017
  14. Prevalence and Persistence of Uremic Symptoms in Incident Dialysis Patients. Kidney360. 2020 Feb; 1(2):86-92.
    View in: PubMed
    Score: 0.017
  15. Resistant hypertension and cardiovascular disease mortality in the US: results from the National Health and Nutrition Examination Survey (NHANES). BMC Nephrol. 2019 04 25; 20(1):138.
    View in: PubMed
    Score: 0.016
  16. Serum Metabolites and Cardiac Death in Patients on Hemodialysis. Clin J Am Soc Nephrol. 2019 05 07; 14(5):747-749.
    View in: PubMed
    Score: 0.016
  17. Integrative Point-of-Care Ultrasound Curriculum to Impart Diagnostic Skills Relevant to Nephrology. Am J Kidney Dis. 2019 06; 73(6):894-896.
    View in: PubMed
    Score: 0.016
  18. Mapping Progress in Reducing Cardiovascular Risk with Kidney Disease: Sudden Cardiac Death. Clin J Am Soc Nephrol. 2018 09 07; 13(9):1429-1431.
    View in: PubMed
    Score: 0.015
  19. Point-of-care ultrasound education to improve care of dialysis patients. Semin Dial. 2018 03; 31(2):154-162.
    View in: PubMed
    Score: 0.014
  20. Measurement and Estimation of Residual Kidney Function in Patients on Dialysis. Adv Chronic Kidney Dis. 2018 01; 25(1):93-104.
    View in: PubMed
    Score: 0.014
  21. Frequency of arrhythmia symptoms and acceptability of implantable cardiac monitors in Hemodialysis patients. BMC Nephrol. 2017 Oct 10; 18(1):309.
    View in: PubMed
    Score: 0.014
  22. Results of the HEMO Study suggest that p-cresol sulfate and indoxyl sulfate are not associated?with?cardiovascular outcomes. Kidney Int. 2017 12; 92(6):1484-1492.
    View in: PubMed
    Score: 0.014
  23. Autonomic dysfunction as a mechanism of intradialytic blood pressure instability. Semin Dial. 2017 11; 30(6):537-544.
    View in: PubMed
    Score: 0.014
  24. Incremental short daily home hemodialysis: a case series. BMC Nephrol. 2017 Jul 05; 18(1):216.
    View in: PubMed
    Score: 0.014
  25. Residual Kidney Function: Implications in the Era of Personalized Medicine. Semin Dial. 2017 05; 30(3):241-245.
    View in: PubMed
    Score: 0.014
  26. Antihypertensive medications and risk of death and hospitalizations in US hemodialysis patients: Evidence from a cohort study to inform hypertension treatment practices. Medicine (Baltimore). 2017 Feb; 96(5):e5924.
    View in: PubMed
    Score: 0.014
  27. Serum Asymmetric and Symmetric Dimethylarginine and Morbidity and Mortality in Hemodialysis Patients. Am J Kidney Dis. 2017 Jul; 70(1):48-58.
    View in: PubMed
    Score: 0.014
  28. CKD to ESRD transition: does assessment of kidney function matter? Nephrol Dial Transplant. 2017 01 01; 32(1):1-3.
    View in: PubMed
    Score: 0.014
  29. Hemodialysis Prescription for Incident Patients: Twice Seems Nice, But Is It Incremental? Am J Kidney Dis. 2016 08; 68(2):180-183.
    View in: PubMed
    Score: 0.013
  30. Trimethylamine N-Oxide and Cardiovascular Events in Hemodialysis Patients. J Am Soc Nephrol. 2017 Jan; 28(1):321-331.
    View in: PubMed
    Score: 0.013
  31. Hand-carried ultrasound use in clinical nephrology: Case report. Medicine (Baltimore). 2016 Jul; 95(30):e4166.
    View in: PubMed
    Score: 0.013
  32. In Reply to 'Plasma Clearance of Iohexol in Hemodialysis Patients Requires Prolonged Blood Sampling'. Am J Kidney Dis. 2016 May; 67(5):811-2.
    View in: PubMed
    Score: 0.013
  33. Association of NTproBNP and cTnI with outpatient sudden cardiac death in hemodialysis patients: the Choices for Healthy Outcomes in Caring for ESRD (CHOICE) study. BMC Nephrol. 2016 Feb 20; 17:18.
    View in: PubMed
    Score: 0.013
  34. Estimating residual kidney function in dialysis patients without urine collection. Kidney Int. 2016 May; 89(5):1099-1110.
    View in: PubMed
    Score: 0.013
  35. Plasma Iohexol Clearance for Assessing Residual Kidney Function in Dialysis Patients. Am J Kidney Dis. 2015 Oct; 66(4):728-30.
    View in: PubMed
    Score: 0.012
  36. Renal Handling of ?-Trace Protein: Interpreting the Evidence. Am J Kidney Dis. 2015 Jun; 65(6):967.
    View in: PubMed
    Score: 0.012
  37. Free Levels of Selected Organic Solutes and Cardiovascular Morbidity and Mortality in Hemodialysis Patients: Results from the Retained Organic Solutes and Clinical Outcomes (ROSCO) Investigators. PLoS One. 2015; 10(5):e0126048.
    View in: PubMed
    Score: 0.012
  38. Troponin I and NT-proBNP and the association of systolic blood pressure with outcomes in incident hemodialysis patients: the Choices for Healthy Outcomes in Caring for ESRD (CHOICE) Study. Am J Kidney Dis. 2014 Sep; 64(3):443-51.
    View in: PubMed
    Score: 0.011
  39. Hypertension in hemodialysis patients: an opinion-based update. Semin Dial. 2014 Mar; 27(2):146-53.
    View in: PubMed
    Score: 0.011
  40. Predialysis systolic BP variability and outcomes in hemodialysis patients. J Am Soc Nephrol. 2014 Apr; 25(4):799-809.
    View in: PubMed
    Score: 0.011
  41. Serum fructosamine and glycated albumin and risk of mortality and clinical outcomes in hemodialysis patients. Diabetes Care. 2013 Jun; 36(6):1522-33.
    View in: PubMed
    Score: 0.010
  42. Serum ?-trace protein and risk of mortality in incident hemodialysis patients. Clin J Am Soc Nephrol. 2012 Sep; 7(9):1435-45.
    View in: PubMed
    Score: 0.010
  43. Comparing the association of GFR estimated by the CKD-EPI and MDRD study equations and mortality: the third national health and nutrition examination survey (NHANES III). BMC Nephrol. 2012 Jun 15; 13:42.
    View in: PubMed
    Score: 0.010
  44. Polyomavirus-associated nephropathy: a comparison of 2 different strategies for immunosuppression reduction. Medicine (Baltimore). 2011 Sep; 90(5):296-302.
    View in: PubMed
    Score: 0.009
  45. Association of residual urine output with mortality, quality of life, and inflammation in incident hemodialysis patients: the Choices for Healthy Outcomes in Caring for End-Stage Renal Disease (CHOICE) Study. Am J Kidney Dis. 2010 Aug; 56(2):348-58.
    View in: PubMed
    Score: 0.009
  46. Changes in serum potassium mediate thiazide-induced diabetes. Hypertension. 2008 Dec; 52(6):1022-9.
    View in: PubMed
    Score: 0.008
  47. Finerenone increases the likelihood of improved KDIGO risk category in patients with CKD and type 2 diabetes: An analysis from FIDELITY. J Diabetes Complications. 2026 Apr; 40(4):109274.
    View in: PubMed
    Score: 0.006
  48. Risk factors for mortality in patients with kidney failure on hemodialysis identified by proteomic analysis of CRIC and PACE studies. Nat Commun. 2025 11 27; 16(1):11689.
    View in: PubMed
    Score: 0.006
  49. Designing a Patient-Centered Interdisciplinary Intervention to Promote Equitable Access to Kidney Transplantation across Health Systems: The STEPS Study. Health Soc Work. 2025 Aug 01; 50(3):219-227.
    View in: PubMed
    Score: 0.006
  50. Rapid and Simultaneous Initiation of Guideline-Directed Kidney Therapies in Patients with CKD and Type 2 Diabetes. J Am Soc Nephrol. 2025 Oct 01; 36(10):2061-2076.
    View in: PubMed
    Score: 0.006
  51. System Interventions to Achieve Early and Equitable Kidney Transplants (STEPS): Protocol for STEPS, a randomized comparative effectiveness clinical trial. Contemp Clin Trials. 2025 06; 153:107911.
    View in: PubMed
    Score: 0.006
  52. Machine learning-based prediction models in medical decision-making in kidney disease: patient, caregiver, and clinician perspectives on trust and appropriate use. J Am Med Inform Assoc. 2025 01 01; 32(1):51-62.
    View in: PubMed
    Score: 0.006
  53. Iohexol plasma clearance measurement protocol standardization for adults: a consensus paper of the European Kidney Function Consortium. Kidney Int. 2024 10; 106(4):583-596.
    View in: PubMed
    Score: 0.006
  54. Plasma metabolites and physical function in patients undergoing hemodialysis. Sci Rep. 2024 04 10; 14(1):8427.
    View in: PubMed
    Score: 0.006
  55. Designing an Implementable Clinical Prediction Model for Near-Term Mortality and Long-Term Survival in Patients on Maintenance Hemodialysis. Am J Kidney Dis. 2024 07; 84(1):73-82.
    View in: PubMed
    Score: 0.006
  56. Metabolites Associated With Uremic Symptoms in Patients With CKD: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study. Am J Kidney Dis. 2024 07; 84(1):49-61.e1.
    View in: PubMed
    Score: 0.006
  57. Hypertensive urgencies and emergencies. Ethn Dis. 2004; 14(4):S2-32-7.
    View in: PubMed
    Score: 0.005
  58. The Clinical and Pathological Characteristics of Patients with Oxalate Nephropathy. Kidney360. 2024 01 01; 5(1):65-72.
    View in: PubMed
    Score: 0.005
  59. Evaluation of a large-scale aptamer proteomics platform among patients with kidney failure on dialysis. PLoS One. 2023; 18(12):e0293945.
    View in: PubMed
    Score: 0.005
  60. Association of urine and plasma ADMA with atherosclerotic risk in DKD cardiovascular disease risk in diabetic kidney disease: findings from the Chronic Renal Insufficiency Cohort (CRIC) study. Nephrol Dial Transplant. 2023 11 30; 38(12):2809-2815.
    View in: PubMed
    Score: 0.005
  61. Hospitalist care. Ann Intern Med. 2003 Oct 21; 139(8):703.
    View in: PubMed
    Score: 0.005
  62. Management of Heart Failure With Reduced Ejection Fraction in Patients With Diabetes Mellitus and Chronic Kidney Disease. Semin Nephrol. 2023 05; 43(3):151429.
    View in: PubMed
    Score: 0.005
  63. Comparative Effectiveness of Alternative Treatment Approaches to Secondary Hyperparathyroidism in Patients Receiving Maintenance Hemodialysis: An Observational Trial Emulation. Am J Kidney Dis. 2024 01; 83(1):58-70.
    View in: PubMed
    Score: 0.005
  64. A Study of Physical Resilience and Aging (SPRING): Conceptual framework, rationale, and study design. J Am Geriatr Soc. 2023 08; 71(8):2393-2405.
    View in: PubMed
    Score: 0.005
  65. Excess risk of cardiovascular events in patients in the United States vs. Japan with chronic kidney disease is mediated mainly by left ventricular structure and function. Kidney Int. 2023 05; 103(5):949-961.
    View in: PubMed
    Score: 0.005
  66. Albuminuria and Heart?Failure: JACC State-of-the-Art Review. J Am Coll Cardiol. 2023 01 24; 81(3):270-282.
    View in: PubMed
    Score: 0.005
  67. Traditions and innovations in assessment of glomerular filtration rate using creatinine to cystatin C. Curr Opin Nephrol Hypertens. 2023 01 01; 32(1):89-97.
    View in: PubMed
    Score: 0.005
  68. Serotonin syndrome induced by amitriptyline, meperidine, and venlafaxine. Ann Pharmacother. 2002 Oct; 36(10):1647-8.
    View in: PubMed
    Score: 0.005
  69. Management of the hospitalized injection drug user. Infect Dis Clin North Am. 2002 Sep; 16(3):571-87.
    View in: PubMed
    Score: 0.005
  70. Physiological Mechanisms of Hypertension and Cardiovascular Disease in End-Stage Kidney Disease. Curr Hypertens Rep. 2022 10; 24(10):413-424.
    View in: PubMed
    Score: 0.005
  71. Deoxycholic Acid and Coronary Artery Calcification in the Chronic Renal Insufficiency Cohort. J Am Heart Assoc. 2022 04 05; 11(7):e022891.
    View in: PubMed
    Score: 0.005
  72. Risk Prediction Models for Atherosclerotic Cardiovascular Disease in Patients with Chronic Kidney Disease: The CRIC Study. J Am Soc Nephrol. 2022 03; 33(3):601-611.
    View in: PubMed
    Score: 0.005
  73. Protein carbamylation and chronic kidney disease progression in the Chronic Renal Insufficiency Cohort Study. Nephrol Dial Transplant. 2021 12 31; 37(1):139-147.
    View in: PubMed
    Score: 0.005
  74. Association of circulating cardiac biomarkers with electrocardiographic abnormalities in chronic kidney disease. Nephrol Dial Transplant. 2021 12 02; 36(12):2282-2289.
    View in: PubMed
    Score: 0.005
  75. Hypertensive Diseases in Pregnancy and Kidney Function Later in Life: The Genetic Epidemiology Network of Arteriopathy (GENOA) Study. Mayo Clin Proc. 2022 01; 97(1):78-87.
    View in: PubMed
    Score: 0.005
  76. Race, Genetic Ancestry, and Estimating Kidney Function in CKD. N Engl J Med. 2021 11 04; 385(19):1750-1760.
    View in: PubMed
    Score: 0.005
  77. Iron status, fibroblast growth factor 23 and cardiovascular and kidney outcomes in chronic kidney disease. Kidney Int. 2021 12; 100(6):1292-1302.
    View in: PubMed
    Score: 0.005
  78. Frailty, Age, and Postdialysis Recovery Time in a Population New to Hemodialysis. Kidney360. 2021 09 30; 2(9):1455-1462.
    View in: PubMed
    Score: 0.005
  79. Kidney Disease Symptoms before and after Kidney Transplantation. Clin J Am Soc Nephrol. 2021 07; 16(7):1083-1093.
    View in: PubMed
    Score: 0.005
  80. Time-Updated Changes in Estimated GFR and Proteinuria and Major Adverse Cardiac Events: Findings from the Chronic Renal Insufficiency Cohort (CRIC) Study. Am J Kidney Dis. 2022 01; 79(1):36-44.e1.
    View in: PubMed
    Score: 0.005
  81. Longitudinal Changes in Prorenin and Renin in the Chronic Renal Insufficiency Cohort. Am J Nephrol. 2021; 52(2):141-151.
    View in: PubMed
    Score: 0.005
  82. Subtyping CKD Patients by Consensus Clustering: The Chronic Renal Insufficiency Cohort (CRIC) Study. J Am Soc Nephrol. 2021 03; 32(3):639-653.
    View in: PubMed
    Score: 0.004
  83. Change in Cardiac Biomarkers and Risk of Incident Heart Failure and Atrial Fibrillation in CKD: The Chronic Renal Insufficiency Cohort (CRIC) Study. Am J Kidney Dis. 2021 06; 77(6):907-919.
    View in: PubMed
    Score: 0.004
  84. Antihyperglycemic Therapies With Expansions of US Food and Drug Administration Indications to Reduce Cardiovascular Events: Prescribing Patterns Within an Academic Medical Center. J Cardiovasc Pharmacol. 2020 09; 76(3):313-320.
    View in: PubMed
    Score: 0.004
  85. Adiposity, Physical Function, and Their Associations With Insulin Resistance, Inflammation, and Adipokines in CKD. Am J Kidney Dis. 2021 01; 77(1):44-55.
    View in: PubMed
    Score: 0.004
  86. Performance of Indexed and Nonindexed Estimated GFR. Am J Kidney Dis. 2020 09; 76(3):446-449.
    View in: PubMed
    Score: 0.004
  87. Kidney Clearance of Secretory Solutes Is Associated with Progression of CKD: The CRIC Study. J Am Soc Nephrol. 2020 04; 31(4):817-827.
    View in: PubMed
    Score: 0.004
  88. Estimating total small solute clearance in patients treated with continuous ambulatory peritoneal dialysis without urine and dialysate collection. Perit Dial Int. 2020 01; 40(1):84-92.
    View in: PubMed
    Score: 0.004
  89. Lower levels of proteinuria are associated with elevated mortality in incident dialysis patients. PLoS One. 2019; 14(12):e0226866.
    View in: PubMed
    Score: 0.004
  90. Markers of mineral metabolism and vascular access complications: The Choices for Healthy Outcomes in Caring for ESRD (CHOICE) study. Hemodial Int. 2020 01; 24(1):43-51.
    View in: PubMed
    Score: 0.004
  91. Race and Mortality in CKD and Dialysis: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study. Am J Kidney Dis. 2020 03; 75(3):394-403.
    View in: PubMed
    Score: 0.004
  92. Differential network enrichment analysis reveals novel lipid pathways in chronic kidney disease. Bioinformatics. 2019 09 15; 35(18):3441-3452.
    View in: PubMed
    Score: 0.004
  93. Cardiac Biomarkers and Risk of Atrial Fibrillation in Chronic Kidney Disease: The CRIC Study. J Am Heart Assoc. 2019 08 06; 8(15):e012200.
    View in: PubMed
    Score: 0.004
  94. Indoxyl sulfate is associated with mortality after AKI - more evidence needed! BMC Nephrol. 2019 07 26; 20(1):280.
    View in: PubMed
    Score: 0.004
  95. Metabolomic profiling to improve glomerular filtration rate estimation: a proof-of-concept study. Nephrol Dial Transplant. 2019 05 01; 34(5):825-833.
    View in: PubMed
    Score: 0.004
  96. Association of Urinary Oxalate Excretion With the Risk of Chronic Kidney Disease Progression. JAMA Intern Med. 2019 04 01; 179(4):542-551.
    View in: PubMed
    Score: 0.004
  97. Hepatitis B virus infection and development of chronic kidney disease: a cohort study. BMC Nephrol. 2018 12 11; 19(1):353.
    View in: PubMed
    Score: 0.004
  98. Vascular Calcification Markers and Hemodialysis Vascular Access Complications. Am J Nephrol. 2018; 48(5):330-338.
    View in: PubMed
    Score: 0.004
  99. Intradialytic Activities and Health-Related Quality of Life Among Hemodialysis Patients. Am J Nephrol. 2018; 48(3):181-189.
    View in: PubMed
    Score: 0.004
  100. Effects of Body Size and Composition on Sex Differences in Measured GFR in a US?Community-Based Older Cohort (MESA-Kidney). Am J Kidney Dis. 2018 11; 72(5):767-770.
    View in: PubMed
    Score: 0.004
  101. Burden and correlates of readmissions related to pulmonary edema in US hemodialysis patients: a cohort study. Nephrol Dial Transplant. 2018 07 01; 33(7):1215-1223.
    View in: PubMed
    Score: 0.004
  102. Hematuria as a risk factor for progression of chronic kidney disease and death: findings from the Chronic Renal Insufficiency Cohort (CRIC) Study. BMC Nephrol. 2018 06 26; 19(1):150.
    View in: PubMed
    Score: 0.004
  103. Metabolomics Research in Chronic Kidney Disease. J Am Soc Nephrol. 2018 06; 29(6):1588-1590.
    View in: PubMed
    Score: 0.004
  104. Nonalcoholic fatty liver disease accelerates kidney function decline in patients with chronic kidney disease: a cohort study. Sci Rep. 2018 03 16; 8(1):4718.
    View in: PubMed
    Score: 0.004
  105. Performance of glomerular filtration rate estimating equations in a community-based sample of Blacks and Whites: the multiethnic study of atherosclerosis. Nephrol Dial Transplant. 2018 03 01; 33(3):417-425.
    View in: PubMed
    Score: 0.004
  106. Performance of non-traditional hyperglycemia biomarkers by chronic kidney disease status in older adults with diabetes: Results from the Atherosclerosis Risk in Communities Study. J Diabetes. 2018 Apr; 10(4):276-285.
    View in: PubMed
    Score: 0.004
  107. Metabolomic Alterations Associated with Cause of CKD. Clin J Am Soc Nephrol. 2017 Nov 07; 12(11):1787-1794.
    View in: PubMed
    Score: 0.004
  108. Non-GFR Determinants of Low-Molecular-Weight Serum Protein Filtration Markers in the Elderly: AGES-Kidney and MESA-Kidney. Am J Kidney Dis. 2017 Sep; 70(3):406-414.
    View in: PubMed
    Score: 0.003
  109. Renal Replacement Therapy and Incremental Hemodialysis for Veterans with Advanced Chronic Kidney Disease. Semin Dial. 2017 05; 30(3):251-261.
    View in: PubMed
    Score: 0.003
  110. Risks of Adverse Events in Advanced CKD: The Chronic Renal Insufficiency Cohort (CRIC) Study. Am J Kidney Dis. 2017 Sep; 70(3):337-346.
    View in: PubMed
    Score: 0.003
  111. The Use of a Multidimensional Measure of Dialysis Adequacy-Moving beyond Small Solute Kinetics. Clin J Am Soc Nephrol. 2017 May 08; 12(5):839-847.
    View in: PubMed
    Score: 0.003
  112. Free and total p-cresol sulfate levels and infectious hospitalizations in hemodialysis patients in CHOICE and HEMO. Medicine (Baltimore). 2017 Feb; 96(6):e5799.
    View in: PubMed
    Score: 0.003
  113. Intravenous iron administration strategies and anemia management in hemodialysis patients. Nephrol Dial Transplant. 2017 01 01; 32(1):173-181.
    View in: PubMed
    Score: 0.003
  114. Effects of Race and Sex on Measured GFR: The Multi-Ethnic Study of Atherosclerosis. Am J Kidney Dis. 2016 Nov; 68(5):743-751.
    View in: PubMed
    Score: 0.003
  115. Effect of a sustained difference in hemodialytic clearance on the plasma levels of p-cresol sulfate and indoxyl sulfate. Nephrol Dial Transplant. 2016 08; 31(8):1335-41.
    View in: PubMed
    Score: 0.003
  116. Kt/Vurea and Nonurea Small Solute Levels in the Hemodialysis Study. J Am Soc Nephrol. 2016 Nov; 27(11):3469-3478.
    View in: PubMed
    Score: 0.003
  117. GFR Estimation Using ?-Trace Protein and ?2-Microglobulin in?CKD. Am J Kidney Dis. 2016 Jan; 67(1):40-8.
    View in: PubMed
    Score: 0.003
  118. Race, Mineral Homeostasis and Mortality in Patients with End-Stage Renal Disease on Dialysis. Am J Nephrol. 2015; 42(1):25-34.
    View in: PubMed
    Score: 0.003
  119. A finger photoplethysmography waveform during the valsalva maneuver detects changes in left heart filling pressure after hemodialysis. BMC Nephrol. 2015 Aug 14; 16:138.
    View in: PubMed
    Score: 0.003
  120. Cross-sectional association of volume, blood pressures, and aortic stiffness with left ventricular mass in incident hemodialysis patients: the Predictors of Arrhythmic and Cardiovascular Risk in End-Stage Renal Disease (PACE) study. BMC Nephrol. 2015 Aug 07; 16:131.
    View in: PubMed
    Score: 0.003
  121. The effects of weight change on glomerular filtration rate. Nephrol Dial Transplant. 2015 Nov; 30(11):1870-7.
    View in: PubMed
    Score: 0.003
  122. Rationale and design for the Predictors of Arrhythmic and Cardiovascular Risk in End Stage Renal Disease (PACE) study. BMC Nephrol. 2015 Apr 24; 16:63.
    View in: PubMed
    Score: 0.003
  123. Effect of intravenous iron use on hospitalizations in patients undergoing hemodialysis: a comparative effectiveness analysis from the DEcIDE-ESRD study. Nephrol Dial Transplant. 2015 Apr; 30(4):667-75.
    View in: PubMed
    Score: 0.003
  124. Intravenous iron exposure and mortality in patients on hemodialysis. Clin J Am Soc Nephrol. 2014 Nov 07; 9(11):1930-9.
    View in: PubMed
    Score: 0.003
  125. Vascular access type, inflammatory markers, and mortality in incident hemodialysis patients: the Choices for Healthy Outcomes in Caring for End-Stage Renal Disease (CHOICE) Study. Am J Kidney Dis. 2014 Dec; 64(6):954-61.
    View in: PubMed
    Score: 0.003
  126. Incidental findings on cardiac computed tomography in incident hemodialysis patients: the predictors of arrhythmic and cardiovascular events in end-stage renal disease (PACE) study. BMC Nephrol. 2014 May 01; 15:68.
    View in: PubMed
    Score: 0.003
  127. An instrumental variable approach finds no associated harm or benefit with early dialysis initiation in the United States. Kidney Int. 2014 Oct; 86(4):798-809.
    View in: PubMed
    Score: 0.003
  128. Comparative effectiveness of early versus conventional timing of dialysis initiation in advanced CKD. Am J Kidney Dis. 2014 May; 63(5):806-15.
    View in: PubMed
    Score: 0.003
  129. Biomarkers of vascular calcification and mortality in patients with ESRD. Clin J Am Soc Nephrol. 2014 Apr; 9(4):745-55.
    View in: PubMed
    Score: 0.003
  130. Trends in anemia management in US hemodialysis patients 2004-2010. BMC Nephrol. 2013 Dec 01; 14:264.
    View in: PubMed
    Score: 0.003
  131. Patterns in blood pressure medication use in US incident dialysis patients over the first 6 months. BMC Nephrol. 2013 Nov 12; 14:249.
    View in: PubMed
    Score: 0.003
  132. Predialysis health, dialysis timing, and outcomes among older United States adults. J Am Soc Nephrol. 2014 Feb; 25(2):370-9.
    View in: PubMed
    Score: 0.003
  133. Non-traditional risk factors are important contributors to the racial disparity in diabetes risk: the atherosclerosis risk in communities study. J Gen Intern Med. 2014 Feb; 29(2):290-7.
    View in: PubMed
    Score: 0.003
  134. Retained organic solutes, patient characteristics and all-cause and cardiovascular mortality in hemodialysis: results from the retained organic solutes and clinical outcomes (ROSCO) investigators. BMC Nephrol. 2013 Jun 27; 14:134.
    View in: PubMed
    Score: 0.003
  135. Association of intradialytic blood pressure variability with increased all-cause and cardiovascular mortality in patients treated with long-term hemodialysis. Am J Kidney Dis. 2013 Jun; 61(6):966-74.
    View in: PubMed
    Score: 0.003
  136. Comparative effectiveness studies to improve clinical outcomes in end stage renal disease: the DEcIDE patient outcomes in end stage renal disease study. BMC Nephrol. 2012 Dec 06; 13:167.
    View in: PubMed
    Score: 0.003
  137. Novel markers of kidney function as predictors of ESRD, cardiovascular disease, and mortality in the general population. Am J Kidney Dis. 2012 May; 59(5):653-62.
    View in: PubMed
    Score: 0.002
  138. Serum potassium and the racial disparity in diabetes risk: the Atherosclerosis Risk in Communities (ARIC) Study. Am J Clin Nutr. 2011 May; 93(5):1087-91.
    View in: PubMed
    Score: 0.002
  139. Serum and dietary potassium and risk of incident type 2 diabetes mellitus: The Atherosclerosis Risk in Communities (ARIC) study. Arch Intern Med. 2010 Oct 25; 170(19):1745-51.
    View in: PubMed
    Score: 0.002
  140. Determinants of blood pressure response to quinapril in black and white hypertensive patients: the Quinapril Titration Interval Management Evaluation trial. Hypertension. 2004 Jun; 43(6):1202-7.
    View in: PubMed
    Score: 0.001
  141. Prevention of hypertension and its complications: theoretical basis and guidelines for treatment. J Am Soc Nephrol. 2003 Jul; 14(7 Suppl 2):S92-8.
    View in: PubMed
    Score: 0.001
  142. Transradial diagnostic and percutaneous coronary intervention. J Coll Physicians Surg Pak. 2003 May; 13(5):242-7.
    View in: PubMed
    Score: 0.001
  143. Allogeneic stem cell transplantation in the myelodysplastic syndromes: interim results of outcome following reduced-intensity conditioning compared with standard preparative regimens. Br J Haematol. 2002 Oct; 119(1):144-54.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.